Skip to main content
. 2014 May 25;14:371. doi: 10.1186/1471-2407-14-371

Table 4.

Risk of CRC and clinicopathological subgrops in relation to HRT and ERT use in colon and rectum

 
Colon
Rectum
 
Tumour subgroups HRT use n HR crude p HR adjusted p n HR crude p HR adjusted p
CRC
No
150
1.00
 
1.00
 
81
1.00
 
1.00
 
ERT
15
1.21(0.71-2.06)
0.488
1.17(0.67-2.02)
0.584
8
0.49(0.23-1.03)
0.061
0.38(0.17-0.86)
0.020
CHRT
28
1.04(0.68-1.57)
0.873
1.16(0.74-1.80)
0.521
13
0.44(0.23-0.86)
0.017
0.32(0.14-0.71)
0.005
T stage 1 & 2
No
27
1.00
 
1.00
 
24
1.00
 
1.00
 
ERT
1
0.52(0.07-3.89)
0.525
0.34(0.04-2.70)
0.308
2
0.32(0.07-1.45)
0.138
0.11(0.02-0.67)
0.017
CHRT
1
0.21(0.03-1.54)
0.125
0.24(0.03-1.90)
0.178
2
0.09(0.01-0.76)
0.026
0.03(0.00-0.36)
0.031
T stage 3 & 4
No
117
1.00
 
1.00
 
42
1.00
 
1.00
 
ERT
13
1.29(0.73-2.30)
0.381
1.30(0.72-2.35)
0.384
4
0.53(0.19-1.48)
0.223
0.51(0.17-1.55)
0.233
CHRT
24
1.17(0.75-1.83)
0.486
1.27(0.78-2.04)
0.335
8
0.72(0.33-1.58)
0.414
0.74(0.28-1.94)
0.533
N0
No
72
1.00
 
1.00
 
45
1.00
 
1.00
 
ERT
11
1.72(0.91-3.26)
0.096
1.54(0.79-3.00)
0.203
3
0.36(0.11-1.20)
0.097
0.31(0.08-1.13)
0.076
CHRT
16
1.20(0.70-2.08)
0.508
1.49(0.83-2.67)
0.183
6
0.29(0.10-0.85)
0.024
0.22(0.06-0.77)
0.222
N1 & N2
No
64
1.00
 
1.00
 
18
1.00
 
1.00
 
ERT
4
0.76(0.28-2.10)
0.596
0.79(0.28-2.23)
0.659
3
1.03(0.30-3.56)
0.959
1.00(0.26-3.92)
1.000
CHRT
10
0.90(0.46-1.77)
0.762
0.79(0.37-1.65)
0.522
5
1.18(0.42-3.34)
0.757
1.00(0.27-3.73)
1.000
M0
No
114
1.00
 
1.00
 
64
1.00
 
1.00
 
ERT
13
1.38(0.77-2.46)
0.277
1.25(0.69-2.26)
0.471
7
0.54(0.24-1.20)
0.130
0.43(0.18-1.03)
0.057
CHRT
22
1.10(0.69-1.74)
0.695
1.21(0.74-1.97)
0.446
12
0.54(0.29-1.09)
0.084
0.42(0.18-0.98)
0.044
M1 No
32
1.00
 
1.00
 
13
1.00
 
1.00
 
ERT
3
1.04(0.32-3.40)
0.953
1.24(0.37-4.16)
0.732
1
0.31(0.04-2.48)
0.269
0.32(0.03-3.24)
0.335
CHRT 6 1.06(0.44-2.56) 0.900 1.13(0.42-3.00) 0.809 1 0.14(0.02-1.22) 0.075 0.06(0.00-1.18) 0.064

Adjusted for age, bmi, educational level, smoking habits and alcohol consumption.